BioMark is proud to partner and cooperate with National Cancer Institute in Bangladesh and BioMark China in a phase III multi site trial. The trail will involve over 400 subjects and will focus on 4 cancer indications. All the procedures will follow North American regulatory guidelines that were prepared by Saint Boniface Research centre’s regulatory group.

News

Cancer Prevention: 5 Actionable Steps
Cancer Prevention: 5 Actionable Steps Take control of your health and reduce your cancer risk